BSE Live
Oct 17, 16:01Prev. Close
6278.00
Open Price
6285.25
Bid Price (Qty.)
6100.00 (1)
Offer Price (Qty.)
6248.40 (10)
NSE Live
Oct 17, 14:47Prev. Close
6284.50
Open Price
6347.00
Bid Price (Qty.)
6200.00 (7)
Offer Price (Qty.)
6205.50 (1)
Key Financial Ratios of Procter and Gamble Health (in Rs. Cr.) | Mar 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 141.00 | 133.00 | 138.00 | 116.00 | 107.00 | |
Diluted EPS (Rs.) | 141.00 | 121.00 | 138.00 | 116.00 | 107.00 | |
Cash EPS (Rs.) | 151.27 | 137.58 | 155.16 | 132.29 | 124.60 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 323.47 | 324.24 | 452.34 | 371.38 | 423.92 | |
Book Value [InclRevalReserve]/Share (Rs.) | 323.47 | 324.24 | 452.34 | 371.38 | 423.92 | |
Dividend / Share(Rs.) | 125.00 | 260.00 | 95.00 | 52.50 | 130.00 | |
Revenue from Operations/Share (Rs.) | 562.75 | 693.53 | 740.73 | 671.33 | 607.67 | |
PBDIT/Share (Rs.) | 198.04 | 193.75 | 206.67 | 169.20 | 159.11 | |
PBIT/Share (Rs.) | 187.98 | 177.25 | 189.74 | 152.89 | 141.01 | |
PBT/Share (Rs.) | 187.72 | 164.65 | 189.28 | 152.63 | 140.53 | |
Net Profit/Share (Rs.) | 141.21 | 121.07 | 138.23 | 115.98 | 106.51 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 35.19 | 27.93 | 27.90 | 25.20 | 26.18 | |
PBIT Margin (%) | 33.40 | 25.55 | 25.61 | 22.77 | 23.20 | |
PBT Margin (%) | 33.35 | 23.74 | 25.55 | 22.73 | 23.12 | |
Net Profit Margin (%) | 25.09 | 17.45 | 18.66 | 17.27 | 17.52 | |
Return on Networth / Equity (%) | 43.65 | 37.34 | 30.55 | 31.22 | 25.12 | |
Return on Capital Employed (%) | 53.90 | 51.13 | 39.50 | 38.57 | 31.32 | |
Return on Assets (%) | 29.51 | 25.30 | 20.83 | 21.54 | 17.92 | |
Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover Ratio (%) | 1.18 | 1.21 | 1.23 | 1.19 | 102.28 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 2.44 | 2.39 | 2.62 | 2.60 | 3.04 | |
Quick Ratio (X) | 1.94 | 1.90 | 2.18 | 2.11 | 2.55 | |
Inventory Turnover Ratio (X) | 8.55 | 2.38 | 2.55 | 2.77 | 8.52 | |
Dividend Payout Ratio (NP) (%) | 99.14 | 206.48 | 40.87 | 147.43 | 215.93 | |
Dividend Payout Ratio (CP) (%) | 92.55 | 181.71 | 36.41 | 129.25 | 184.57 | |
Earnings Retention Ratio (%) | 0.86 | -106.48 | 59.13 | -47.43 | -115.93 | |
Cash Earnings Retention Ratio (%) | 7.45 | -81.71 | 63.59 | -29.25 | -84.57 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 8,347.67 | 8,138.39 | 8,273.45 | 6,626.39 | 8,817.13 | |
EV/Net Operating Revenue (X) | 8.94 | 7.07 | 6.73 | 5.95 | 8.74 | |
EV/EBITDA (X) | 25.39 | 25.30 | 24.12 | 23.59 | 33.38 | |
MarketCap/Net Operating Revenue (X) | 9.14 | 7.28 | 7.09 | 6.24 | 9.21 | |
Retention Ratios (%) | 0.85 | -106.48 | 59.12 | -47.43 | -115.93 | |
Price/BV (X) | 15.90 | 15.57 | 11.60 | 11.28 | 13.20 | |
Price/Net Operating Revenue | 9.14 | 7.28 | 7.09 | 6.24 | 9.21 | |
Earnings Yield | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 |
10.09.2025
Procter Gamble Standalone June 2025 Net Sales at Rs 338.74 crore, up 19.33% Y-o-Y
01.08.2025
Procter Gamble Standalone June 2025 Net Sales at Rs 338.74 crore, up 19.33% Y-o-Y
30.05.2025
Procter Gamble Standalone March 2025 Net Sales at Rs 310.99 crore, up 23.17% Y-o-Y
05.11.2024
Procter&Gamble Standalone September 2024 Net Sales at Rs 313.41 crore, up 2.78% Y-o-Y